Impact Biomedical IBO
NYSE IBO
$3.80 -0.22 (-5.47%)
As of: Oct 22, 2026 · 3:58 PM EDT

Impact Biomedical (IBO) EBT (2022 - 2026)

Updated

Impact Biomedical (IBO) reported EBT of -$700,000 for Q2 2026, compared with -$14.35 million a year earlier.

Analysis

Impact Biomedical (IBO) EBT (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Impact Biomedical's EBT came in at -$18.81 million; for FY2024, it was -$24.74 million.

  • By year, EBT came in at -$4.41 million in FY2023 and -$7.88 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly EBT since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 34.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 4.28 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.80 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -653.00 Mn
10 Impact Biomedical 428.05 Mn 428.01 Mn 2,000.00 -700,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -700,000.00
Mar 31, 2026 -2.28 Mn
Sep 30, 2025 -1.48 Mn
Jun 30, 2025 -14.35 Mn
Mar 31, 2025 -1.28 Mn
Dec 31, 2024 -27.10 Mn
Sep 30, 2024 4.24 Mn
Jun 30, 2024 -884,000.00
Mar 31, 2024 -998,000.00
Dec 31, 2023 -1.26 Mn
Sep 30, 2023 -1.18 Mn
Jun 30, 2023 -1.12 Mn
Mar 31, 2023 -849,000.00
Dec 31, 2022 -5.25 Mn
Sep 30, 2022 -978,000.00
Jun 30, 2022 -799,000.00
API Access

Impact Biomedical EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=IBO&period=max&api_key=YOUR_API_KEY